Cognex Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.30 Cr
as on 20-12-2024
- Paid Up Capital ₹ 5.00 M
as on 20-12-2024
- Company Age 44 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 4.44 Cr
as on 20-12-2024
- Revenue %
(FY 2018)
- Profit 78.66%
(FY 2018)
- Ebitda 5.43%
(FY 2018)
- Net Worth -2.92%
(FY 2018)
- Total Assets -6.77%
(FY 2018)
About Cognex Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.30 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.44 Cr.
Satyanarayana Gangavaram, Bhaskar Poralla, Sampath Vijayaraghavan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG1980PLC002680
- Company No.
002680
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 May 1980
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cognex Pharma Limited offer?
Cognex Pharma Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Cognex Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Gangavaram  | Managing Director | 16-Oct-1989 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhaskar Poralla | Director | 16-Oct-1989 | Current |
| Sampath Vijayaraghavan | Director | 27-Oct-2005 | Current |
| Bhaskar Atla | Additional Director | 28-Mar-2018 | Current |
| Naga Chanda | Additional Director | 10-Jan-2018 | Current |
Financial Performance of Cognex Pharma.
Cognex Pharma Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.66% increase in profit. The company's net worth dipped by a decrease of 2.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cognex Pharma?
In 2018, Cognex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bless Pharma India Private LimitedActive 9 years 16 daysBhaskar Atla and Naga Chanda are mutual person
Charges (Loans)
₹4.44 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 3.74 Cr
- Andhra Bank : 0.35 Cr
- A.P.S.F.C. Chirag Ali Lane : 0.20 Cr
- State Bank Of India : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2003 | Punjab National Bank | ₹1.50 M | Open |
| 22 Mar 2003 | Punjab National Bank | ₹3.59 Cr | Open |
| 07 Aug 1995 | State Bank Of India | ₹1.52 M | Open |
| 04 Dec 1991 | A.P.S.F.C. Chirag Ali Lane | ₹1.79 M | Open |
| 17 May 1990 | Andhra Bank | ₹3.51 M | Open |
How Many Employees Work at Cognex Pharma?
Unlock and access historical data on people associated with Cognex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cognex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cognex Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
